Highly efficient and sensitive patient-specific quality assurance for spot-scanned proton therapy.
The purpose of this work was to develop an end-to-end patient-specific quality assurance (QA) technique for spot-scanned proton therapy that is more sensitive and efficient than traditional approaches. The patient-specific methodology relies on independently verifying the accuracy of the delivered p...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2019-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0212412 |
| _version_ | 1819016864804634624 |
|---|---|
| author | J E Johnson C Beltran H Wan Chan Tseung D W Mundy J J Kruse T J Whitaker M G Herman K M Furutani |
| author_facet | J E Johnson C Beltran H Wan Chan Tseung D W Mundy J J Kruse T J Whitaker M G Herman K M Furutani |
| author_sort | J E Johnson |
| collection | DOAJ |
| description | The purpose of this work was to develop an end-to-end patient-specific quality assurance (QA) technique for spot-scanned proton therapy that is more sensitive and efficient than traditional approaches. The patient-specific methodology relies on independently verifying the accuracy of the delivered proton fluence and the dose calculation in the heterogeneous patient volume. A Monte Carlo dose calculation engine, which was developed in-house, recalculates a planned dose distribution on the patient CT data set to verify the dose distribution represented by the treatment planning system. The plan is then delivered in a pre-treatment setting and logs of spot position and dose monitors, which are integrated into the treatment nozzle, are recorded. A computational routine compares the delivery log to the DICOM spot map used by the Monte Carlo calculation to ensure that the delivered parameters at the machine match the calculated plan. Measurements of dose planes using independent detector arrays, which historically are the standard approach to patient-specific QA, are not performed for every patient. The nozzle-integrated detectors are rigorously validated using independent detectors in regular QA intervals. The measured data are compared to the expected delivery patterns. The dose monitor reading deviations are reported in a histogram, while the spot position discrepancies are plotted vs. spot number to facilitate independent analysis of both random and systematic deviations. Action thresholds are linked to accuracy of the commissioned delivery system. Even when plan delivery is acceptable, the Monte Carlo second check system has identified dose calculation issues which would not have been illuminated using traditional, phantom-based measurement techniques. The efficiency and sensitivity of our patient-specific QA program has been improved by implementing a procedure which independently verifies patient dose calculation accuracy and plan delivery fidelity. Such an approach to QA requires holistic integration and maintenance of patient-specific and patient-independent QA. |
| first_indexed | 2024-12-21T02:54:25Z |
| format | Article |
| id | doaj.art-6075562a9702466baeb3123df1c14b25 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-21T02:54:25Z |
| publishDate | 2019-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-6075562a9702466baeb3123df1c14b252022-12-21T19:18:23ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01142e021241210.1371/journal.pone.0212412Highly efficient and sensitive patient-specific quality assurance for spot-scanned proton therapy.J E JohnsonC BeltranH Wan Chan TseungD W MundyJ J KruseT J WhitakerM G HermanK M FurutaniThe purpose of this work was to develop an end-to-end patient-specific quality assurance (QA) technique for spot-scanned proton therapy that is more sensitive and efficient than traditional approaches. The patient-specific methodology relies on independently verifying the accuracy of the delivered proton fluence and the dose calculation in the heterogeneous patient volume. A Monte Carlo dose calculation engine, which was developed in-house, recalculates a planned dose distribution on the patient CT data set to verify the dose distribution represented by the treatment planning system. The plan is then delivered in a pre-treatment setting and logs of spot position and dose monitors, which are integrated into the treatment nozzle, are recorded. A computational routine compares the delivery log to the DICOM spot map used by the Monte Carlo calculation to ensure that the delivered parameters at the machine match the calculated plan. Measurements of dose planes using independent detector arrays, which historically are the standard approach to patient-specific QA, are not performed for every patient. The nozzle-integrated detectors are rigorously validated using independent detectors in regular QA intervals. The measured data are compared to the expected delivery patterns. The dose monitor reading deviations are reported in a histogram, while the spot position discrepancies are plotted vs. spot number to facilitate independent analysis of both random and systematic deviations. Action thresholds are linked to accuracy of the commissioned delivery system. Even when plan delivery is acceptable, the Monte Carlo second check system has identified dose calculation issues which would not have been illuminated using traditional, phantom-based measurement techniques. The efficiency and sensitivity of our patient-specific QA program has been improved by implementing a procedure which independently verifies patient dose calculation accuracy and plan delivery fidelity. Such an approach to QA requires holistic integration and maintenance of patient-specific and patient-independent QA.https://doi.org/10.1371/journal.pone.0212412 |
| spellingShingle | J E Johnson C Beltran H Wan Chan Tseung D W Mundy J J Kruse T J Whitaker M G Herman K M Furutani Highly efficient and sensitive patient-specific quality assurance for spot-scanned proton therapy. PLoS ONE |
| title | Highly efficient and sensitive patient-specific quality assurance for spot-scanned proton therapy. |
| title_full | Highly efficient and sensitive patient-specific quality assurance for spot-scanned proton therapy. |
| title_fullStr | Highly efficient and sensitive patient-specific quality assurance for spot-scanned proton therapy. |
| title_full_unstemmed | Highly efficient and sensitive patient-specific quality assurance for spot-scanned proton therapy. |
| title_short | Highly efficient and sensitive patient-specific quality assurance for spot-scanned proton therapy. |
| title_sort | highly efficient and sensitive patient specific quality assurance for spot scanned proton therapy |
| url | https://doi.org/10.1371/journal.pone.0212412 |
| work_keys_str_mv | AT jejohnson highlyefficientandsensitivepatientspecificqualityassuranceforspotscannedprotontherapy AT cbeltran highlyefficientandsensitivepatientspecificqualityassuranceforspotscannedprotontherapy AT hwanchantseung highlyefficientandsensitivepatientspecificqualityassuranceforspotscannedprotontherapy AT dwmundy highlyefficientandsensitivepatientspecificqualityassuranceforspotscannedprotontherapy AT jjkruse highlyefficientandsensitivepatientspecificqualityassuranceforspotscannedprotontherapy AT tjwhitaker highlyefficientandsensitivepatientspecificqualityassuranceforspotscannedprotontherapy AT mgherman highlyefficientandsensitivepatientspecificqualityassuranceforspotscannedprotontherapy AT kmfurutani highlyefficientandsensitivepatientspecificqualityassuranceforspotscannedprotontherapy |